Spiroplasma eriocheiris Entry in Drosophila S2 Cells via End
2026-05-06
This study elucidates the mechanisms by which Spiroplasma eriocheiris invades Drosophila Schneider 2 (S2) cells, demonstrating a reliance on clathrin-mediated endocytosis and macropinocytosis. The findings advance understanding of invertebrate-pathogen interactions and provide a methodological framework for dissecting host cell entry, cytoskeletal involvement, and apoptotic responses.
Applied Workflows for YM-155 Hydrochloride Survivin Inhibito
2026-05-05
YM-155 hydrochloride stands out as a potent, highly selective survivin inhibitor for apoptosis research, with proven efficacy across diverse cancer models. This article delivers advanced experimental workflows, protocol enhancements, and troubleshooting insights to maximize data quality and translational impact.
CK2-Mediated Phosphorylation Modulates Plant Ceramide Syntha
2026-05-05
This study reveals that phosphorylation by casein kinase 2 (CK2) fine-tunes the activity and stability of LOH2, a key ceramide synthase in Arabidopsis, thereby modulating sphingolipid biosynthesis and immune responses. The findings clarify post-translational regulation of sphingolipid metabolism and provide new insights into plant defense signaling.
Coumestrol Drives Ferroptosis to Suppress RA Synoviocyte Act
2026-05-04
This study reveals that coumestrol induces ferroptosis in rheumatoid arthritis fibroblast-like synoviocytes (RA-FLS) by stabilizing mitochondrial PMAIP1 via TRIM3 pathway inhibition, resulting in reduced cell proliferation and inflammation. These insights suggest ferroptosis modulation as a promising therapeutic strategy for RA and provide mechanistic benchmarks for future ferroptosis assays.
Optimizing Lab Assays with DIDS (4,4'-Diisothiocyanostilbene
2026-05-04
This article addresses practical challenges in cell viability, proliferation, and cytotoxicity assays, illustrating how DIDS (4,4'-Diisothiocyanostilbene-2,2'-disulfonic Acid) (SKU B7675) from APExBIO improves data reliability and mechanistic clarity. Scenario-driven Q&A blocks, each grounded in peer-reviewed literature and protocol nuance, guide researchers in leveraging DIDS for robust chloride channel inhibition and advanced pathway interrogation.
AZD0156 (SKU B7822): Reliable ATM Kinase Inhibition in Lab A
2026-05-03
This article provides a scenario-driven, evidence-based guide to using AZD0156 (SKU B7822), a potent and selective ATM kinase inhibitor, for cell viability, proliferation, and cytotoxicity assays. It addresses real laboratory challenges with actionable solutions, referencing peer-reviewed data and validated protocols. Researchers will find practical insights on assay design, data interpretation, and supplier reliability, ensuring reproducibility and confidence in cancer research workflows.
Thapsigargin (SKU B6614): Precision SERCA Pump Inhibition in
2026-05-02
This article details how Thapsigargin (SKU B6614) from APExBIO addresses common laboratory challenges in apoptosis, calcium signaling, and ER stress research. Through scenario-driven Q&A, we highlight protocol optimization, data reliability, and vendor choice, providing actionable guidance for biomedical researchers seeking robust, reproducible results.
Technical Guide: Angiotensin I/II (1-5) in RAS Research
2026-05-02
Angiotensin I/II (1-5) provides a standardized Asp-Arg-Val-Tyr-Ile peptide fragment for rigorous modeling of the renin-angiotensin system, especially in studies targeting hypertension and aldosterone signaling. It is technically optimized for cardiovascular and renal research but is not indicated for unrelated peptide signaling workflows or exploratory off-target applications.
Dual-Action Inhibitors Accelerate p38α Dephosphorylation Mec
2026-05-01
This study uncovers how certain kinase inhibitors not only block p38α MAPK activity but also promote its dephosphorylation by stabilizing a conformation more accessible to phosphatases. The findings clarify mechanisms for achieving greater inhibitor specificity and potency, with implications for research on inflammation, cancer, and drug resistance.
Applied Use of Erlotinib in EGFR Signaling Pathway Inhibitio
2026-04-30
Erlotinib (NSC 718781) delivers robust, selective EGFR inhibition for cancer research, with precise protocol control critical for reproducible results. This guide details practical workflows, troubleshooting, and data-driven applications to maximize reliability and insight in EGFR-targeted assays.
Paroxetine Mesylate: Applied Protocols for Oncology Research
2026-04-30
Paroxetine Mesylate bridges selective serotonin reuptake inhibition with multi-kinase targeting, enabling robust workflows in both neuropharmacology and oncology. This article delivers actionable protocol parameters, advanced comparative insights, and troubleshooting expertise, making it an essential guide for researchers pursuing translational cancer models and beyond.
Applied Workflows with EZ Cap Cy5 Firefly Luciferase mRNA
2026-04-29
EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP) empowers researchers with real-time visualization of mRNA delivery and robust, quantifiable translation using dual-modality detection. This guide explores stepwise protocols, troubleshooting tactics, and advanced use-cases, grounded in peer-reviewed innovations and practical lab experience.
Dovitinib (TKI-258): Precision RTK Inhibition for Assay Inno
2026-04-29
Explore the scientific depth of Dovitinib (TKI-258) as a multitargeted RTK inhibitor, with a focus on quantitative assay design, downstream signaling, and translational research implications. This article delivers unique, protocol-driven insights for advanced cancer research.
CBD Modulates Pain and Affect via Cannabinoid and Serotonin
2026-04-28
This study demonstrates that cannabidiol (CBD) robustly attenuates orofacial inflammatory pain and associated affective deficits through coordinated actions on peripheral and central mechanisms. The findings highlight the role of endocannabinoid and serotonergic pathways in mediating both sensory and emotional aspects of pain, underscoring the therapeutic potential of CBD for complex pain syndromes.
Practical Use of Protease Inhibitor Cocktail (EDTA-Free, 200
2026-04-28
The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) provides broad-spectrum protection against protein degradation during extraction and analysis workflows, especially when downstream applications are sensitive to EDTA. It is not suitable for workflows requiring metalloprotease inhibition via chelators or where DMSO-sensitive steps are involved.
509 records 23/34 page Previous Next First page 上5页 2122232425 下5页 Last page